OTC Bulletin Board

S & P Company Insight for APPLIED DNA SCIENCES
 
 Profile

 
Business Summary: Applied DNA Sciences, Inc. provides botanical DNA encryption, embedment, and authentication solutions in the United States and Europe.
 
Address
  25 Health Sciences Drive
  Suite 113
  Stony Brook , NY 11790
  Phone: 631-444-6862
  Website: http://www.adnas.com
Auditor
  RBSM
  McLean
Transfer Agent
  Securities Transfer Corp.
Employees:  7
ShareHolders:  1283
Founded:  1983
Domicile:  Nevada
 
  
 
 Background

 
Applied DNA Sciences, Inc. provides botanical DNA encryption, embedment, and authentication solutions in the United States and Europe. Its solutions protect companies, governments, and consumers from counterfeiting, fraud, piracy, product diversion, identity theft, and unauthorized intrusion into physical locations and databases. The company's SigNature Program provides a means to incorporate its SigNature DNA Markers in, and then authenticate and identify a range of items, such as artwork and collectibles, fine wine, consumer products, digital media, financial instruments, identity cards, and other official documents. Applied DNA Sciences was founded in 1983 and is headquartered in Stony Brook, New York.
History:  INCORPORATED in Nevada Apr. 20, 1998, as DCC Acquisition Corp.; and on Dec. 20, 1998, merged DataLink Capital Corp., a Florida corporation, to effect a change in domicile to Nevada. The company's name changed to ProHealth Medical Technologies, Inc. Oct. 27, 1999; and to Applied DNA Sciences, Inc. in connection with the merger, effective Oct. 31, 2002, of the company's wholly owned subsidiary, Applied DNA Sciences, Inc., into the company. The company acquired Applied DNA Sciences, Inc. (incorporated Sept. 16, 2002) on Oct. 21, 2002, for 11,000,000 Common shares. DataLink Capital Corp., the Florida corporation, was incorporated Jan. 26, 1983, as Datalink Systems, Inc.; name changed to Datalink Capital Corp. Apr. 29, 1987, to Midland Capital Resources, Inc. Apr. 26, 1991, and to DataLink Capital Corp. Sept. 29, 1997.
 
 
 
 
  
 
 Management

 

Management
OfficersPosition
 James  HaywardChairman, President, Investor Relations Contact & Chief Executive Officer
 Kurt H. JensenChief Financial Officer, Chief Accounting Officer & Controller
 Ming-Hwa Benjamin LiangSecretary

Directors
 Scott R. Griffiths
 James  Hayward
 Yacov  Shamash
 Jesse  Shelmire
 Sanford R. Simon
 
  
 
 Annual Report

 
Annual Report
 
Income Statement
  20072006
Sales121,92018,900
Cost of sales23,07315,639
General and administrative expenses12,096,4448,530,354
Impairment of intangible assets--5,655,011
Research and development110,845153,191
Depreciation and Amortization432,5821,370,299
Net gain in revaluation of debt derivative and warrant liabilities1,387,93216,844,837
Other income, net97779,488
Interest expense, net2,152,7183,628,968
Net loss(13,304,833)(2,410,237)
Share earns. basic($0.10)($0.02)
Share earns. diluted($0.10)($0.02)
Average shares135,229,885116,911,022
 
Balance Sheet
  2007
ASSETS
Current Assets:
Cash25,185
Restricted cash 399,920
Prepaid expenses101,000
Total Current Assets526,105
Net Property, Plant and Equipment105,537
Deposits13,822
Capitalized finance costs29,503
Intangible assets1,736,821
TOTAL ASSETS2,411,788
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable and accrued liabilities13,215,975
Note payable 740,405
Other current liabilities 399,920
Total Current Liabilities14,356,300
STOCKHOLDERS' EQUITY
Convertible Preferred Stock, par value $0.001 per share6
Common Stock, par value $0.50 per share180,281
Additional paid in capital128,448,584
Accumulated deficit(140,573,383)
Total Stockholders' Equity(11,944,512)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY2,411,788
Preferred Shares60,000
Common Shares180,281,661
 
  
 
 Interim Report

 
Interim Report   
 
Data Not Available
 
 
 
 
  
 
 Pro Forma Report

 
Pro Forma Report   
 
Data Not Available
 
 
 
 
  
 
 Quarterly Report

 
Quarterly Report Information   
 
Quarterly Revenue, US$
YearQuarterRevenue
  2008   1120,000
  2008   2210,000
  2007   1Nil
  2007   2Nil
  2007   3Nil
  2007   Full Year 120,000
  2006   1Nil
  2006   2Nil
  2006   320,000
  2006   Full Year 20,000
  2005   1Nil
  2005   2Nil
  2005   Full Year Nil
  2004   1Nil
  2004   2Nil
  2004   3Nil
  2004   Full Year Nil
  2003   3Nil
  2003   Full Year Nil
 
 
Quarterly Net Income, US$
YearQuarterRevenue
  2008   1(2,130,000)
  2008   2(1,330,000)
  2007   1(670,000)
  2007   2(9,370,000)
  2007   31,810,000
  2007   Full Year (13,300,000)
  2006   1(2,440,000)
  2006   23,360,000
  2006   3760,000
  2006   Full Year (2,410,200)
  2005   1(12,370,000)
  2005   2(16,810,000)
  2005   Full Year (52,610,400)
  2004   1(7,540,000)
  2004   2(2,440,000)
  2004   32,230,000
  2004   Full Year (19,358,300)
  2003   3(330,000)
  2003   Full Year (3,445,000)
 
 
Quarterly EPS, US$
YearQuarterRevenue
  2008   1(.01)
  2008   2(.01)
  2007   1(.01)
  2007   2(.08)
  2007   3(.02)
  2007   Full Year (.10)
  2006   1(.02)
  2006   2.03
  2006   3.01
  2006   Full Year (.02)
  2005   1(.45)
  2005   2(.31)
  2005   Full Year (.82)
  2004   1(.41)
  2004   2(.12)
  2004   3(.10)
  2004   Full Year (.93)
  2003   3(.02)
  2003   Full Year (.27)
 
  
 
 Stock Data

 
 
Capitalization as of 03/31/2008:
 
 Authorized SharesOutstanding Shares
Preferred $0.001 par10,000,00060,000so1
Common $0.001 par250,000,000192,136,603
 
LONG TERM DEBT: None.
 
Common $0.0001 par
 
Stockholders:  01/10/2008, 1283.
Transfer Agent:  Securities Transfer Corp.   Frisco , TX
 
OTC Bulletin Board( Primary): APDN
 
ExchangeYearHighLow
OTC Bulletin Board20070.28000.0800
OTC Bulletin Board20060.37000.0700
OTC Bulletin Board20051.83000.1600
OTC Bulletin Board20043.55000.4200
OTC Bulletin Board20033.54002.0000
OTC Bulletin Board20022.50000.0500
 
DIVIDENDS: Common $0.0001 par: None.
 
 
  so1Closely held.